Shares Outstanding Shares Outstanding n/a Close	66.61M
Shares Change (YoY) Shares Change (YoY) n/a Close	2.92%
Shares Change (QoQ) Shares Change (QoQ) n/a Close	1.21%
Owned by Institutions (%) Owned by Institutions (%) n/a Close	99.99%
Shares Floating Shares Floating n/a Close	65.98M
Failed to Deliver (FTD) Shares Failed to Deliver (FTD) Shares n/a Close	99
FTD / Avg. Volume FTD / Avg. Volume n/a Close	0.01%

Short Selling Information

The latest short interest is 7.83M, so 11.79% of the outstanding shares have been sold short.

Short Interest Short Interest n/a Close	7.83M
Short % of Shares Out Short % of Shares Out n/a Close	11.79%
Short % of Float Short % of Float n/a Close	18.12%
Short Ratio (days to cover) Short Ratio (days to cover) n/a Close	5.72

Valuation Ratios

The PE ratio is -24.55 and the forward PE ratio is -32.44. Tandem Diabetes Care's PEG ratio is 0.43.

PE Ratio PE Ratio n/a Close	-24.55
Forward PE Forward PE n/a Close	-32.44
PS Ratio PS Ratio n/a Close	2.51
Forward PS Forward PS n/a Close	0.9
PB Ratio PB Ratio n/a Close	8.96
P/FCF Ratio P/FCF Ratio n/a Close	472.08
PEG Ratio PEG Ratio n/a Close	0.43

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Tandem Diabetes Care.

EV / Sales EV / Sales n/a Close	n/a
EV / EBITDA EV / EBITDA n/a Close	n/a
EV / EBIT EV / EBIT n/a Close	n/a
EV / FCF EV / FCF n/a Close	n/a

Financial Position

The company has a current ratio of 2.93, with a Debt / Equity ratio of 1.8.

Current Ratio Current Ratio n/a Close	2.93
Quick Ratio Quick Ratio n/a Close	2.33
Debt / Equity Debt / Equity n/a Close	1.8
Debt / EBITDA Debt / EBITDA n/a Close	-4.78
Debt / FCF Debt / FCF n/a Close	94.83
Interest Coverage Interest Coverage n/a Close	-13.37

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity Return on Equity n/a Close	n/a
Return on Assets Return on Assets n/a Close	n/a
Return on Invested Capital Return on Invested Capital n/a Close	n/a
Revenue Per Employee Revenue Per Employee n/a Close	$354,793.58
Profits Per Employee Profits Per Employee n/a Close	$-36,235.85
Employee Count Employee Count n/a Close	2,650
Asset Turnover Asset Turnover n/a Close	0.97
Inventory Turnover Inventory Turnover n/a Close	3.01

Taxes

Income Tax Income Tax n/a Close	4.16M
Effective Tax Rate Effective Tax Rate n/a Close	-4.52%

Stock Price Statistics

The stock price has increased by -53.49% in the last 52 weeks. The beta is 1.52, so Tandem Diabetes Care's price volatility has been higher than the market average.

Beta Beta n/a Close	1.52
52-Week Price Change 52-Week Price Change n/a Close	-53.49%
50-Day Moving Average 50-Day Moving Average n/a Close	19.91
200-Day Moving Average 200-Day Moving Average n/a Close	29.84
Relative Strength Index (RSI) Relative Strength Index (RSI) n/a Close	45.01
Average Volume (20 Days) Average Volume (20 Days) n/a Close	1,508,882

Income Statement

In the last 12 months, Tandem Diabetes Care had revenue of 940.2M and earned -96.03M in profits. Earnings per share was -1.47.

Revenue Revenue n/a Close	940.2M
Gross Profit Gross Profit n/a Close	489.57M
Operating Income Operating Income n/a Close	-99.13M
Net Income Net Income n/a Close	-96.03M
EBITDA EBITDA n/a Close	-99.13M
EBIT EBIT n/a Close	-99.28M
Earnings Per Share (EPS) Earnings Per Share (EPS) n/a Close	-1.47

Full Income Statement

Balance Sheet

The company has 69.23M in cash and 473.56M in debt, giving a net cash position of -404.33M.

Cash & Cash Equivalents Cash & Cash Equivalents n/a Close	69.23M
Total Debt Total Debt n/a Close	473.56M
Net Cash Net Cash n/a Close	-404.33M
Retained Earnings Retained Earnings n/a Close	-1.05B
Total Assets Total Assets n/a Close	922.14M
Working Capital Working Capital n/a Close	375.26M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 24.23M and capital expenditures -19.23M, giving a free cash flow of 4.99M.

Operating Cash Flow Operating Cash Flow n/a Close	24.23M
Capital Expenditures Capital Expenditures n/a Close	-19.23M
Free Cash Flow Free Cash Flow n/a Close	4.99M
FCF Per Share FCF Per Share n/a Close	0.08

Full Cash Flow Statement

Margins

Gross margin is 52.07%, with operating and profit margins of -10.54% and -10.21%.

Gross Margin Gross Margin n/a Close	52.07%
Operating Margin Operating Margin n/a Close	-10.54%
Pretax Margin Pretax Margin n/a Close	-9.77%
Profit Margin Profit Margin n/a Close	-10.21%
EBITDA Margin EBITDA Margin n/a Close	-10.54%
EBIT Margin EBIT Margin n/a Close	-10.54%
FCF Margin FCF Margin n/a Close	0.53%

Dividends & Yields

TNDM does not appear to pay any dividends at this time.

Dividend Per Share Dividend Per Share n/a Close	n/a
Dividend Yield Dividend Yield n/a Close	n/a
Dividend Growth (YoY) Dividend Growth (YoY) n/a Close	n/a
Payout Ratio Payout Ratio n/a Close	n/a
Earnings Yield Earnings Yield n/a Close	n/a
FCF Yield FCF Yield n/a Close	n/a

Dividend Details

Analyst Forecast

The average price target for TNDM is $24, which is 20% higher than the current price. The consensus rating is "Hold".

Price Target Price Target n/a Close	$24
Price Target Difference Price Target Difference n/a Close	20%
Analyst Consensus Analyst Consensus n/a Close	Hold
Analyst Count Analyst Count n/a Close	13

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value Lynch Fair Value n/a Close	n/a
Lynch Upside Lynch Upside n/a Close	n/a
Graham Number Graham Number n/a Close	n/a
Graham Upside Graham Upside n/a Close	n/a

Stock Splits

The last stock split was on Oct 10, 2017. It was a backward split with a ratio of 1:10.

Last Split Date Last Split Date n/a Close	Oct 10, 2017
Split Type Split Type n/a Close	backward
Split Ratio Split Ratio n/a Close	1:10

Scores

Altman Z-Score Altman Z-Score n/a Close	0.4
Piotroski F-Score Piotroski F-Score n/a Close	5